Here are five things to know:
1. The plans also kept their exclusive positive coverage for SI-BONE’s iFuse Implant System, which went into effect Jan. 1.
2. The updated policy took effect July 15.
3. The updated policy reads: “use of minimally invasive or percutaneous SIJ fusion products other than titanium triangular implants/devices (e.g., iFuse Implant System) is considered experimental, investigational and/or unproven.”
4. SelectHealth in Utah and Geisinger in Pennsylvania also offer exclusive positive coverage for the iFuse Implant System.
5. The iFuse Implant System is designed to fuse the SI joint via its triangular titanium implants.
More articles on MIS:
Inspired Spine hosts 2nd Annual Minimally Invasive Spine Conference: 6 highlights
1st ZIP ULTRA minimally invasive spine surgery performed in Argentina: 5 highlights
1st MIS spine surgery complete with Medicrea’s patient-specific implant: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.